Sign Up Today and Learn More About AccuVein Stock
Invest in or calculate the value of your shares in AccuVein or other pre-IPO companies through EquityZen's platform.
AccuVein Stock (ACCV)
AccuVein develops products that aid in the visualization of peripheral vasculature.
About AccuVein Stock
Founded
2006
Headquarters
Medford, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
AccuVein specializes in vein visualization technology. Its flagship product, the AV400, is a hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. The company was founded in 2006 and is headquartered in Medford, New York.
AccuVein Press Mentions
Stay in the know about the latest news on AccuVein
Micro vein enhancer with two lasers and two optical detectors configured for …
patents • Apr 14, 2024
Automatic alignment of a contrast enhancement system
patents • Apr 14, 2024
Device for Detecting and Illuminating the Vasculature Using an FPGA
patents • Apr 14, 2024
Vein Scanner Configured for Single-Handed Lifting and Use
patents • Apr 14, 2024
Vein Imaging Device with Differential Image Resolution at the Center and the …
patents • Apr 14, 2024
AccuVein Management
Leadership team at AccuVein
Director
James D. Lackie
Director
Jimmy Lackie
Join now and verify your accreditation status to gain access to:
- AccuVein current valuation
- AccuVein stock price
- Available deals in AccuVein and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in AccuVein stock?
Accredited investors can buy pre-IPO stock in companies like AccuVein through EquityZen funds. These investments are made available by existing AccuVein shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AccuVein stock?
Shareholders can sell their AccuVein stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
